Abstract
Arginine, a conditionally nonessential amino acid, is synthesized from citrulline by the sequential action of the cytosolic enzymes argininosuccinate synthetase and argininosuccinate lyase in the body and does not need to be obtained directly through the diet. However, since this biosynthetic pathway does not produce sufficient amounts of arginine, some needs to be consumed through the diet. This amino acid plays an important role in cell division, the healing of wounds, removal of ammonia from the body, immune function, and the regulation of cardiovascular aspects (Masumoto et al., Nutrition 27:1141–1145, 2011; Zhu et al., Innate Immun 19:242–252, 2013; Lorin et al., Mol Nutr Food Res 58:101–116, 2014). In addition, arginine is the precursor of nitric oxide (NO), which is synthesized from this amino acid by NO synthase, an enzyme involved in the modulation of various biological actions mainly through the activation of guanylyl cyclase under physiological conditions (Whittle, Physiology of the Gastrointestinal Tract, 1994). Several studies (Okabe et al., Arzneimittel-Forschung 26:534–537, 1997; Takeuchi et al., Jpn J Pharmacol 61:13–21, 1993; Tanaka et al., J Physiol Pharmacol 50:405–417, 1999; Ohno et al., J Pharmacol Exp Ther 310:821–827, 2004; Nagahama et al., Dig Dis Sci 51:303–309, 2006; Nagahama et al., Med Sci Monit 18:BR9–BR15, 2012) demonstrated that arginine exhibited protective effects against various lesion models in the gastrointestinal tract, including the esophagus. Although the mechanisms responsible have yet to be elucidated, the protective effects were reportedly related to processes dependent on or independent of NO (Tanaka et al., J Physiol Pharmacol 50:405–417, 1999; Ohno et al., J Pharmacol Exp Ther 310:821–827, 2004; Nagahama et al., Dig Dis Sci 51:303–309, 2006; Nagahama et al., Med Sci Monit 18:BR9–BR15, 2012).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Masumoto K, Nagata K, Oka Y, Kai H, et al. Successful treatment of an infected wound in infants by a combination of negative pressure wound therapy and l-arginine supplementation. Nutrition. 2011;27:1141–5.
Zhu HL, Liu YL, Xie XL, et al. Effect of l-arginine on intestinal mucosal immune barrier function in weaned pigs after Escherichia coli LPS challenge. Innate Immun. 2013;19:242–52.
Lorin J, Zeller M, Guilland JC, et al. l-Arginine and nitric oxide synthase: regulatory mechanisms and cardiovascular aspects. Mol Nutr Food Res. 2014;58:101–16.
Whittle BJR. Nitric oxide in gastrointestinal physiology and pathology. In: Johnson LR, editor. Physiology of the gastrointestinal tract. 3rd ed. New York: Raven; 1994. p. 267–94.
Okabe S, Takeuchi K, Honda K, et al. Effects of various amino acids on gastric lesions induced by acetylsalicylic acid and gastric secretion in pylorus-ligated rats. Arzneimittelforschung. 1997;26:534–7.
Takeuchi K, Ohuchi T, Kato S, et al. Cytoprotective action of l-arginine against HCl-induced gastric injury in rats: involvement of nitric oxide? Jpn J Pharmacol. 1993;61:13–21.
Tanaka A, Kunikata T, Konaka A, et al. Dual action of nitric oxide in pathogenesis of indomethacin-induced small intestinal ulceration in rats. J Physiol Pharmacol. 1999;50:405–17.
Ohno R, Yokota A, Tanaka A, et al. Induction of small intestinal damage in rats following combined treatment with cyclooxygenase-2 and nitric oxide synthase inhibitors. J Pharmacol Exp Ther. 2004;310:821–7.
Nagahama K, Yamato M, Nishio H, et al. Essential role of pepsin in pathogenesis of acid reflux esophagitis in rats. Dig Dis Sci. 2006;51:303–9.
Nagahama K, Nishio H, Yamato M, et al. Orally administered l-arginine and glycine are highly effective against acid reflux esophagitis in rats. Med Sci Monit. 2012;18:BR9–15.
Orlando RC. Pathogenesis of reflux esophagitis and Barrett’s esophagus. Med Clin North Am. 2005;89:219–41.
Hunt RH. Importance of pH control in the management of GERD. Arch Intern Med. 1999;159:649–57.
Bell NJ, Burget D, Howden CW, et al. Appropriate acid suppression for the management of gastro-oesophageal reflux disease. Digestion. 1992;51 Suppl 1:59–67.
Hamamoto N, Hashimoto T, Adachi K, et al. Comparative study of nizatidine and famotidine for maintenance therapy of erosive esophagitis. J Gastroenterol Hepatol. 2005;20:281–6.
Nagahama K, Yamato M, Kato S, et al. Protective effect of lafutidine, a novel H2 receptor antagonist on acid reflux esophagitis in rats through capsaicin-sensitive afferent neurons. J Pharmacol Sci. 2003;93:55–61.
Inatomi N, Nagaya H, Takami K, et al. Effects of a proton pump inhibitor, AG-1749 (lansoprazole), on reflux esophagitis and experimental ulcers in rats. Jpn J Pharmacol. 1991;55:437–51.
Takeuchi K, Nagahama K. Animal model of acid-reflux esophagitis: pathogenic roles of acid/pepsin, prostaglandins, and amino acids. BioMed Res Int. 2014;2014:1–10.
Umezawa H, Aoyagi T, Morishima H, et al. Pepstatin, a new pepsin inhibitor produced by actinomycetes. J Antibiot. 1970;23:259–62.
Kunimoto S, Aoyagi T, Morishima H, et al. Mechanism of inhibition of pepsin by pepstatin. J Antibiot. 1972;25:251–5.
Souza RF, Huo X, Mittal V, et al. Gastroesophageal reflux might cause esophagitis through a cytokine-mediated mechanism rather than caustic acid injury. Gastroenterology 2009; 137: 1776–84.
De Backer A, Haentjens P, Willems G. Hydrochloric acid: a trigger of cell proliferation in the esophagus of dogs. Dig Dis Sci. 1994;9:884–90.
Hollwarth ME, Smith ME, Kvietys RP, et al. Esophageal blood flow in the cat: normal distribution and effects of acid perfusion. Gastroenterology. 1986;90:622–8.
Yamato M, Nagahama K, Kotani T, et al. Biphasic effect of prostaglandin E2 on a rat model of esophagitis mediated by EP1 receptors: relation to pepsin secretion. Digestion. 2005;72:109–18.
Takeuchi K, Kato S, Amagase K. Prostaglandin EP receptors involved in modulating gastrointestinal mucosal integrity. J Pharmacol Sci. 2010;114:248–61.
Lanas AI, Blas JM, Ortego J, et al. Adaptation of esophageal mucosa to acid- and pepsin-induced damage: role of nitric oxide and epidermal growth factor. Dig Dis Sci. 1997;42:1003–12.
Konturek PC, Brozowska I, Targosz A, et al. Esophagoprotection mediated by esogenous and endogenous melatonin in an experimental model of reflux esophagitis. J Pineal Res 2013; 55: 46-57..
Ishiyama F, Iijima K, Asanuma K, et al. Exogenous luminal nitric oxide exacerbates esophagus tissue damage in a reflux esophagitis model of rats. Scand J Gastroenterol. 2009;44:527–37.
Ito Y, Okuda S, Ohkawa F, et al. Dual role of nitric oxide in gastric hypersecretion in distended stomach: inhibition of acid secretion and stimulation of pepsin secretion. Life Sci. 2008;83:886–92.
Urushidani T, Okabe S, Takeuchi K, et al. Effects of various amino acids on indomethacin-induced gastric ulcers in rats. Jpn J Pharmacol. 1977;27:316–9.
Kitagawa H, Ikejiri T, Nishiwaki H, et al. Endothelium-dependent adaptive gastric protection. Jpn J Pharmacol. 1992;58(Supp 1):131P.
Szolcsányi J, Barthó L. Capsaicin-sensitive afferents and their role in gastroprotection: an update. J Physiol Paris. 2001;95:181–8.
Onodera S, Nishida K, Takeuchi K. Unique profile of lafutidine, a novel histamine H2-receptor antagonist: mucosal protection throughout gastrointestinal tract mediated by capsaicin-sensitive afferent neurons. Drug Des Rev Online. 2004;1:133–44.
Yamamoto H, Hirata T, Araki H, et al. Inducible types of cyclooxygenase and nitric oxide synthase in adaptive cytoprotection in rat stomachs. J Physiol Paris. 1999;93:405–12.
Matsumoto J, Takeuchi K, Ueshima K, et al. Role of capsaicin-sensitive afferent neurons in mucosal blood flow response of rat stomach induced by mild irritants. Dig Dis Sci. 1992;37:1336–44.
Robert A, Nezamis JE, Lancaster C, et al. Mild irritants prevent gastric necrosis through “adaptive cytoprotection” mediated by prostaglandins. Am J Physiol. 1983;245:G113–21.
Nobuhara Y, Takeuchi K, Okabe S. Vinegar is a dietary mild irritant to the rat gastric mucosa. Jpn J Pharmacol. 1986;41:101–8.
Takeuchi K, Nishiwaki H, Ueshima K, et al. Gastric motility as a possible mechanism of gastric cytoprotection in the rat. In: Kitajima M, editor. Cytoprotection and Cyto-biology. Tokyo: Excerpta Medica; 1992. p. 15–21.
Takeuchi K, Nishiwaki H, Okada M, et al. Mucosal protective action of histamine against gastric lesions induced by HCl in rats: importance of antigastric motor activity mediated by H2-receptors. J Pharmacol Exp Ther. 1988;245:632–8.
Statement of Conflict of Interest
The authors declare that there is no conflict of interests regarding the publication of this manuscript.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Takeuchi, K. (2017). Mucosal Protection by l-Arginine in the Upper Gastrointestinal Tract. In: Patel, V., Preedy, V., Rajendram, R. (eds) L-Arginine in Clinical Nutrition. Nutrition and Health. Humana Press, Cham. https://doi.org/10.1007/978-3-319-26009-9_29
Download citation
DOI: https://doi.org/10.1007/978-3-319-26009-9_29
Published:
Publisher Name: Humana Press, Cham
Print ISBN: 978-3-319-26007-5
Online ISBN: 978-3-319-26009-9
eBook Packages: MedicineMedicine (R0)